MARKET

ALZN

ALZN

Alzamend Neuro Inc
NASDAQ
2.340
0.000
0.00%
After Hours: 2.340 0 0.00% 19:59 01/08 EST
OPEN
2.340
PREV CLOSE
2.340
HIGH
2.350
LOW
2.293
VOLUME
41.78K
TURNOVER
--
52 WEEK HIGH
11.70
52 WEEK LOW
1.690
MARKET CAP
8.90M
P/E (TTM)
-0.4101
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ALZN last week (1229-0102)?
Weekly Report · 3d ago
Director Milton C. Ault III Reports Sale of Alzamend Neuro Inc. Common Shares
Reuters · 12/30/2025 22:54
Weekly Report: what happened at ALZN last week (1222-1226)?
Weekly Report · 12/29/2025 09:58
Ascendiant Sticks to Their Buy Rating for Alzamend Neuro (ALZN)
TipRanks · 12/24/2025 12:15
Director William B. Horne Reports Disposal of Alzamend Neuro Inc. Common Shares
Reuters · 12/23/2025 21:30
Alzamend Neuro Price Target Cut to $28.00/Share From $42.00 by Ascendiant Capital
Dow Jones · 12/22/2025 12:24
ALZAMEND NEURO INC <ALZN.O>: ASCENDIANT CAPITAL MARKETS CUTS TARGET PRICE TO $28 FROM $42
Reuters · 12/22/2025 11:59
Weekly Report: what happened at ALZN last week (1215-1219)?
Weekly Report · 12/22/2025 09:57
More
About ALZN
Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing novel products for the treatment of Alzheimer's disease (Alzheimer's), bipolar disorder (BD), major depressive disorder (MDD) and post-traumatic stress disorder (PTSD). The Company's pipeline consists of two novel therapeutic drug candidates: AL001, and ALZN002. AL001 is a patented ionic cocrystal technology delivering a therapeutic combination of lithium, salicylate and L-proline through three royalty-bearing exclusive worldwide licenses from the University of South Florida Research Foundation, Inc., (the Licensor). AL001 is used for Alzheimer's, BD, MDD and PTSD treatment. ALZN002 is a patented method using a mutant peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient’s immunological system to combat Alzheimer's by removing beta-amyloid from the brain through a royalty-bearing exclusive worldwide license from the Licensor.

Webull offers Alzamend Neuro Inc stock information, including NASDAQ: ALZN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALZN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALZN stock methods without spending real money on the virtual paper trading platform.